
Glimismall MP 1mg/500mg/15mg Tablet
Marketer
Ambitious Pharmaceutical Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimismall MP 1mg/500mg/15mg Tablet
Metformin-glimepiride-pioglitazone (1mg/500mg/15mg) tablets offer a multi-component approach to managing elevated blood glucose. This medication, used alongside a balanced diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen. Ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular schedule. Never double the dose; exceeding the recommended amount may cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessments will be conducted before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimismall MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimismall MP 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimismall MP 1mg/500mg/15mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
Common Side effects of Glimismall MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimismall MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Glimismall MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Glimismall MP 1mg/500mg/15mg Tablet works:
Glimismall MP (1mg/500mg/15mg) tablets combine three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple-drug approach improves blood sugar management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimismall MP 1mg/500mg/15mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Glimismall MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimismall MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Exercise caution when administering Glimismall MP 1mg/500mg/15mg tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimismall MP 1mg/500mg/15mg tablets. Physician consultation is recommended. Regular assessment of kidney function is advised during treatment with this medication.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glimismall MP 1mg/500mg/15mg tablets, as dosage modifications may be necessary. Medical advice should be sought. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimismall MP 1mg/500mg/15mg Tablet :
Should you forget to take your Glimismall MP 1mg/500mg/15mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimismall MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
